Treatment of herniated lumbar disc by percutaneous laser disc decompression combined with synchronous suction technique through syringe

Objective： To compare the outcomes of percutaneous laser disc decompression （PLDD） and PLDD with synchronous suction through syringe in the patients with herniated lumbar disc（HLD）. Methods： Forty-two patients with HLD on MRI and those who did not respond to conservative treatment for 6 weeks were randomly divided into group A and group B. In group A, the patients were treated with PLDD and those in group B with PLDD and synchronous suction through syringe. GaAIAS diode laser at 810 nm was used for the ablation in both groups. The treatment effect was evaluated by modified MacNab＇s criteria on the 7^th, 30^th and 90^th day. Results： Evaluated by modified MacNab＇s criteria, the percentages of the excellent and good cases in total patients treated for group B and A were 80.95% and 57.14% on the 7^th follow-up day, 85.71% and 66.67% on the 30^th follow-up day, and 95.24% and 71.43% on the 90^th follow-up day, respectively. Conclusion： Synchronous suction technique through syringe during PLDD improves the overall outcome in the treatment of herniated lumbar disc.     

Safety assessment for octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)-propionate (CAS Reg. No. 2082-79-3) from use in food contact applications

Octadecyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate (CAS Reg. No. 2082-79-3), currently marketed as Irganox 1076 (I-76), is a sterically hindered phenolic antioxidant used in a variety of organic substrates, including those used in the manufacture of food contact articles. In 2012, the US Food and Drug Administration (USFDA), Office of Food Additive Safety (OFAS), initiated a post-market re-evaluation of the food contact applications of I-76. This project aimed to ensure that current dietary exposures from the use of I-76 in food contact articles are accurately captured and the safety assessment considered all relevant and available toxicological information. To accomplish these aims, the USFDA reviewed the available toxicological studies and chemistry information on food contact applications of I-76. Based on this in-depth analysis, a NOAEL of 64 mg/kg-bw/d (female rats) from a chronic rat study and a cumulative estimated dietary intake (CEDI) of 4.5 mg/p/d, was used to calculate a margin of exposure (MOE) of ∼850. We concluded that the previous and current exposure levels provide an adequate margin of safety (MOS) and remain protective of human health for the regulated uses.     

Cyber.rules – What you really need to know about the Internet

Over the next three issues three linked articles will take you through guidance about how to write for publication. In 2009 and 2010 Taylor &; Francis funded two workshops on this topic for members of the British Association for Sexual and Relationship Therapy. Using some of the exercises and feedback from these workshops the article will consider: common anxieties that therapists have about writing and how to address these; some of the main forms of writing that counsellors and therapists can consider; key aspects of structure and content; and how to go through the process of submission, review and revision. It is hoped that the articles will go some way towards demystifying the process and increasing your confidence in writing and submitting publications.     

卵泡期长效长方案在卵巢储备良好但前次黄体期短效长方案助孕失败患者中的应用:一项自身对照研究

目的:探讨卵泡期长效长方案对卵巢储备功能良好但前次黄体期短效长方案助孕失败患者的妊娠结局是否有所改善。方法:回顾性分析106例前次黄体期短效长方案助孕失败后行卵泡期长效长方案再次助孕的卵巢储备功能良好(AFC5)患者212个周期的临床资料,按照促排卵方案分为黄体期短效长方案(A组)与卵泡期长效长方案(B组)。结果:Gn启动日E2值、hCG注射日E2值和子宫内膜厚度以及移植胚胎数组间比较均无统计学差异(P0.05)。B组Gn启动日、hCG注射日血LH值和早期流产率均显著低于A组(P0.001),而Gn使用总剂量、Gn使用天数、获卵数、MII卵数、MII卵率、2PN数、可移植胚胎数、胚胎种植率、生化妊娠及临床妊娠率均显著高于A组(P0.001)。结论:在卵巢储备功能良好但前次黄体期短效长方案助孕失败的女性中,再次助孕采用卵泡期长效长方案可显著提高获卵数及卵子质量,并显著提高妊娠率,降低早期流产率,是理想的治疗方案。     

恶性肿瘤临终患者善终认知的质性研究

目的了解恶性肿瘤临终患者对生命走向终结的真实感受以及对善终的理解期望,为临终关怀护理提供依据。方法采用现象学研究与参与式观察相结合的方法,对16例恶性肿瘤患者就死亡和善终的话题进行深入访谈。结果恶性肿瘤临终患者对善终的认知包括3个主题13个副主题:生理方面为没有躯体疼痛、避免过度医疗、保持身体完整;心理方面为社交需求、保持尊严、拥有自主、心愿达成、后事交代、家庭和谐、精神慰藉;社会方面为经济状况、医疗资源、医疗照护。结论医护人员应深入了解恶性肿瘤患者的感受和身心需求,做到合理病情告知,适度医疗,减轻痛苦;同时加强医护人员善终相关知识与技能的培训,增加临终关怀病房和宁养机构,最大可能帮助患者实现善终。     

Rural residents' perspectives on the rural ‘good death’: a scoping review

The ‘good death’ is one objective of palliative care, with many ‘good death’ viewpoints and research findings reflecting the urban voice. Rural areas are distinct and need special consideration. This scoping review identified and charted current research knowledge on the ‘good’ rural death through the perspectives of rural residents, including rural patients with a life‐limiting illness, to identify evidence and gaps in the literature for future studies. A comprehensive literature search of English language articles (no date filter applied) was conducted in 2016 (2 January to 14 February) using five library databases. Reference lists of included articles, recent issues of eight relevant journals and three grey literature databases were also hand‐searched. Twenty articles (for 17 studies and one systematic review) were identified after a two‐phase screening process by two reviewers, using pre‐determined inclusion criteria. Data from each study were extracted and charted, analysed using a thematic analysis of the included articles' content, and with a quantitative analysis of the scoping review. These papers revealed data collected from rural patients with a life‐limiting illness and family caregivers, rural healthcare providers, the wider rural community, rural community leaders and rural health administrators and policy makers. Rural locations were heterogeneous. Residents from developed and developing countries believe a ‘good death’ is one that is peaceful, free of pain and without suffering; however, this is subjective and priorities are based on personal, cultural, social and religious perspectives. Currently, there is insufficient data to generalise rural residents' perspectives and what it means for them to die well. Given the extreme importance of a ‘good death’, there is a need for further studies to elicit rural patient and family caregiver perspectives.     

大鼠胎脑神经细胞与胶原复合体移植对脑损伤的修复

目的:评价胶原蛋白(Collagen)的细胞相容性;研究胶原蛋白(C)与大鼠胎脑神经细胞(FBN)复合体(C-FBN)脑内移植对脑损伤的修复作用。方法:将大鼠FBN与胶原蛋白联合体外培养,进行光镜、扫描电镜观察。并将体外联合培养3～5d的C-FBN(移植前48h培养液中加入BrdU)移植到大脑皮质损伤模型的大鼠脑损伤部位,术后3,6,10,15及30d光镜、BrdU免疫细胞化学染色(ICC)、透射电镜观察脑组织对移植物的反应、移植细胞生长状态及载体在体内的降解情况等。结果:胶原蛋白对FBN生长无不良影响;脑组织对移植物无明显的免疫排斥反应;胶原蛋白与周围脑组织整合好,有血管长入移植物中;载体内有大量存活神经细胞,而且术后各时段都检出BrdU阳性细胞;移植区有突触形成;胶原蛋白海绵吸收、降解快,可诱导组织再生。结论:胶原具有良好的细胞相容性和组织相容性,是神经组织工程的一种较为理想的生物载体材料;生物材料与胎脑神经细胞联合培养移植是治疗脑损伤较有前途的新方法。     

GLP实验室供试品管理的常见问题与对策

目的规范供试品管理,使其符合《药物非临床研究质量管理规范》（Good Laboratory Practice,GLP）的要求。方法查找供试品管理各环节存在的问题。结果分析总结了保管、配制、分析等主要环节较易出现的问题并提出意见和建议。结论通过完善供试品管理,关注每一环节的细节操作,真正实现了供试品的有效管理。